share_log

Avenue Therapeutics | CORRESP: CORRESP

Avenue Therapeutics | CORRESP: CORRESP

Avenue Therapeutics | CORRESP:信函
美股sec公告 ·  05/08 12:46
Moomoo AI 已提取核心訊息
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, based in Bay Harbor Islands, Florida, submitted the request via EDGAR on May 8, 2024, with the desired effective date being 4:00 p.m. Eastern time on May 10, 2024, or as soon as possible thereafter. The request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David S. Wolpa, attorneys from its outside legal counsel Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the Registration Statement's effective status with its legal representatives upon approval.
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, based in Bay Harbor Islands, Florida, submitted the request via EDGAR on May 8, 2024, with the desired effective date being 4:00 p.m. Eastern time on May 10, 2024, or as soon as possible thereafter. The request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David S. Wolpa, attorneys from its outside legal counsel Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the Registration Statement's effective status with its legal representatives upon approval.
avenue therapeutics公司已正式向證券交易委員會(SEC)提交請求加速其S-3表格的註冊聲明生效日期。總部位於佛羅里達州海灣島的公司於2024年5月8日通過EDGAR提交了請求,所需生效日期爲2024年5月10日華東時間下午4點,或儘快在此之後。該請求是根據1933年證券法的規則461提出的。avenue therapeutics已授權其外部法律顧問Troutman Pepper Hamilton Sanders LLP的Rakesh Gopalan和David S. Wolpa律師在必要時修改或撤回加速請求。該公司已要求SEC在獲得批准後向其法律代表確認登記聲明的有效狀態。
avenue therapeutics公司已正式向證券交易委員會(SEC)提交請求加速其S-3表格的註冊聲明生效日期。總部位於佛羅里達州海灣島的公司於2024年5月8日通過EDGAR提交了請求,所需生效日期爲2024年5月10日華東時間下午4點,或儘快在此之後。該請求是根據1933年證券法的規則461提出的。avenue therapeutics已授權其外部法律顧問Troutman Pepper Hamilton Sanders LLP的Rakesh Gopalan和David S. Wolpa律師在必要時修改或撤回加速請求。該公司已要求SEC在獲得批准後向其法律代表確認登記聲明的有效狀態。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息